ERBB2 and liver cancer: We then investigated the tissue-specific KO of Srsf3 on cancer induction in two well-established mouse cancer models: activated rat c-neu (V664E) replacement of mouse Erbb2-induced breast cancer (32) (Erbb2 breast cancer in this report), and DEN-induced liver cancer (33) (Figure 1A).